PA8452001A1 - Derivados de macrolidos c-4" sustituidos - Google Patents

Derivados de macrolidos c-4" sustituidos

Info

Publication number
PA8452001A1
PA8452001A1 PA19988452001A PA8452001A PA8452001A1 PA 8452001 A1 PA8452001 A1 PA 8452001A1 PA 19988452001 A PA19988452001 A PA 19988452001A PA 8452001 A PA8452001 A PA 8452001A PA 8452001 A1 PA8452001 A1 PA 8452001A1
Authority
PA
Panama
Prior art keywords
formula
compounds
refers
macrolides
derivatives
Prior art date
Application number
PA19988452001A
Other languages
English (en)
Inventor
Brian Scott Bronk
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PA8452001A1 publication Critical patent/PA8452001A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

ESTA INVENCION SE REFIERE A LOS COMPUESTOS DE FORMULA Y A LAS SALES FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS. LOS COMPUESTOS DE FORMULA 1 SON POTENTES AGENTES ANTIBACTERIANOS QUE PUEDEN UTILIZARSE PARA TRATAR DIVERSAS INFECCIONES BACTERIANAS Y TRASTORNOS RELACIONADOS CON LAS MISMAS. LA INVENCION TAMBIEN SE REFIERE A LAS COMPOSICIONES FARMACEUTICAS QUE CONTIENEN LOS COMPUESTOS DE FORMULA 1 Y A LOS METODOS PARA EL TRATAMIENTO DE LAS INFECCIONES BACTERIANAS MEDIANTE LA ADMINISTRACION DE LOS COMPUESTOS DE FORMULA 1. LA INVENCION TAMBIEN SE REFIERE A LOS METODOS PARA LA PREPARACION DE LOS COMPUESTOS DE FORMULA 1 Y LOS PRODUCTOS INTERMEDIOS UTILES PARA DICHA PREPARACION.
PA19988452001A 1997-06-11 1998-05-22 Derivados de macrolidos c-4" sustituidos PA8452001A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4998097P 1997-06-11 1997-06-11

Publications (1)

Publication Number Publication Date
PA8452001A1 true PA8452001A1 (es) 2000-05-24

Family

ID=21962765

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19988452001A PA8452001A1 (es) 1997-06-11 1998-05-22 Derivados de macrolidos c-4" sustituidos

Country Status (40)

Country Link
EP (1) EP0988309B1 (es)
JP (1) JP3262806B2 (es)
KR (1) KR100369959B1 (es)
CN (1) CN1145636C (es)
AP (1) AP1189A (es)
AR (1) AR013085A1 (es)
AT (1) ATE310742T1 (es)
AU (1) AU745006C (es)
BG (1) BG64357B1 (es)
BR (1) BR9810097A (es)
CA (1) CA2293397C (es)
CO (1) CO4950584A1 (es)
DE (1) DE69832486T2 (es)
DZ (1) DZ2515A1 (es)
EA (1) EA002440B1 (es)
ES (1) ES2251081T3 (es)
GT (1) GT199800075A (es)
HK (1) HK1025974A1 (es)
HN (1) HN1998000074A (es)
HR (1) HRP980315A2 (es)
HU (1) HUP0004076A3 (es)
ID (1) ID24530A (es)
IL (1) IL132808A (es)
IS (1) IS1979B (es)
MA (1) MA24563A1 (es)
MY (1) MY133027A (es)
NO (1) NO315560B1 (es)
NZ (1) NZ500652A (es)
OA (1) OA11226A (es)
PA (1) PA8452001A1 (es)
PE (1) PE79999A1 (es)
PL (1) PL337497A1 (es)
SK (1) SK168299A3 (es)
TN (1) TNSN98084A1 (es)
TW (2) TW200418871A (es)
UA (1) UA70298C2 (es)
UY (1) UY25041A1 (es)
WO (1) WO1998056801A1 (es)
YU (1) YU62999A (es)
ZA (1) ZA985016B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
EP1779853A3 (en) * 1997-09-10 2010-01-27 Merial Ltd. 9a-azalides as veterinary antimicrobial agents
JP2001515865A (ja) * 1997-09-10 2001-09-25 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての９ａ−アザライド
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
EP1437360A3 (en) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11 Carbamates of macrolide antibacterials
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
AU5995299A (en) 1998-11-03 2000-05-22 Pfizer Products Inc. Novel macrolide antibiotics
CA2411293A1 (en) * 1999-01-28 2000-07-28 Pfizer Products Inc. Novel azalides and methods of making same
AU6748500A (en) * 1999-08-24 2001-03-19 Abbott Laboratories 9a-azalides with antibacterial activity
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
DE60003586T2 (de) * 2000-01-27 2004-01-08 Pfizer Products Inc., Groton Antibiotische azalid-zusammensetzungen
RU2263117C2 (ru) * 2001-04-27 2005-10-27 Пфайзер Продактс Инк. Способ получения 4"-замещенных производных 9-деоксо-9а-аза-9а-гомоэритромицина а
JP2003040782A (ja) * 2001-05-31 2003-02-13 Pfizer Prod Inc アザリド抗生物質組成物
EP1551865B1 (en) 2002-07-08 2009-04-22 GlaxoSmithKline istrazivacki centar Zagreb d.o.o. Hybrid molecules of macrolides with steroidal/non-steroidal anti-inflammatory molecules
CA2489402A1 (en) 2002-07-08 2004-01-15 Pliva-Istrazivacki Institut D.O.O. New compounds, compositions and methods for treatment of inflammatory diseases and conditions
PL374646A1 (en) * 2002-07-08 2005-10-31 Pliva-Istrazivacki Institutt D.O.O. Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
EP1638549A4 (en) * 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
US7276487B2 (en) 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
EP1723159B1 (en) 2004-02-27 2019-06-12 Melinta Therapeutics, Inc. Macrocyclic compounds and methods of making and using the same
EP2177526A4 (en) 2007-08-06 2012-08-22 Taisho Pharmaceutical Co Ltd 10A-AZALIDE COMPOUND CROSS-LINKED IN POSITION 10A AND POSITION 12
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
WO2009139181A1 (ja) 2008-05-15 2009-11-19 大正製薬株式会社 ４員環構造を有する１０ａ－アザライド化合物
US8796232B2 (en) 2008-10-24 2014-08-05 Cempra Pharmaceuticals, Inc. Methods for treating resistant diseases using triazole containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
WO2012038372A1 (en) * 2010-09-20 2012-03-29 Novartis Ag Novel process for the preparation of 9-deoxo-9a-aza- 9a-homoerythromycin a modified in the c-4'' of the cladinose ring by an epoxide group
AR085286A1 (es) * 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
CN104470527B (zh) 2012-03-27 2019-05-28 森普拉制药公司 用于施用大环内酯抗生素的肠胃外制剂
JP5857008B2 (ja) * 2012-08-20 2016-02-10 大正製薬株式会社 Ｃ−４”位置換マクロライド誘導体を含有する医薬
CA3130061A1 (en) * 2013-04-04 2014-10-09 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
CN105669798B (zh) * 2013-08-23 2019-07-26 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN103965273B (zh) * 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
AR102810A1 (es) 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd Derivado de macrólido sustituido en la posición c-4
JP2017531663A (ja) 2014-10-08 2017-10-26 プレジデント アンド フェローズ オブ ハーバード カレッジ １４員ケトライドならびにそれらの調製および使用の方法
CA2980315A1 (en) 2015-03-25 2016-09-29 President And Fellows Of Harvard College Macrolides with modified desosamine sugars and uses thereof
CN108003207B (zh) 2017-12-19 2019-05-10 海门慧聚药业有限公司 制备泰拉霉素的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE445223B (sv) * 1977-02-04 1986-06-09 Pfizer Sett att framstella 4"-amino-erytomylin-a-derivat
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
DE3475073D1 (en) * 1983-09-06 1988-12-15 Pfizer Azahomoerythromycin b derivatives and intermediates thereof
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US5412982A (en) * 1994-03-10 1995-05-09 Potts; James K. Windsock support

Also Published As

Publication number Publication date
CN1145636C (zh) 2004-04-14
KR20010013633A (ko) 2001-02-26
BR9810097A (pt) 2000-08-08
TW200418871A (en) 2004-10-01
IL132808A (en) 2004-08-31
MA24563A1 (fr) 1998-12-31
CA2293397C (en) 2004-08-31
HUP0004076A3 (en) 2003-05-28
IS1979B (is) 2005-01-14
TNSN98084A1 (fr) 2005-03-15
PL337497A1 (en) 2000-08-28
CN1259955A (zh) 2000-07-12
ID24530A (id) 2000-07-20
UY25041A1 (es) 2000-09-29
HN1998000074A (es) 1999-01-08
ZA985016B (en) 1999-12-10
WO1998056801A1 (en) 1998-12-17
UA70298A (uk) 2004-10-15
EP0988309A1 (en) 2000-03-29
GT199800075A (es) 1999-11-30
TWI224106B (en) 2004-11-21
HK1025974A1 (en) 2000-12-01
ES2251081T3 (es) 2006-04-16
KR100369959B1 (ko) 2003-02-12
DZ2515A1 (fr) 2003-02-01
NO996107L (no) 2000-02-10
AU745006B2 (en) 2002-03-07
BG103969A (en) 2000-07-31
OA11226A (en) 2003-07-16
AU7228198A (en) 1998-12-30
CA2293397A1 (en) 1998-12-17
BG64357B1 (bg) 2004-11-30
SK168299A3 (en) 2000-09-12
MY133027A (en) 2007-10-31
HUP0004076A2 (hu) 2001-04-28
NO996107D0 (no) 1999-12-10
NO315560B1 (no) 2003-09-22
IS5250A (is) 1999-11-16
EA002440B1 (ru) 2002-04-25
EA199901014A1 (ru) 2000-06-26
CO4950584A1 (es) 2000-09-01
AR013085A1 (es) 2000-12-13
YU62999A (sh) 2002-10-18
AP1189A (en) 2003-07-16
IL132808A0 (en) 2001-03-19
PE79999A1 (es) 1999-08-25
AU745006C (en) 2006-02-23
EP0988309B1 (en) 2005-11-23
ATE310742T1 (de) 2005-12-15
DE69832486D1 (de) 2005-12-29
UA70298C2 (uk) 2004-10-15
JP2000514097A (ja) 2000-10-24
DE69832486T2 (de) 2006-07-27
HRP980315A2 (en) 1999-04-30
NZ500652A (en) 2001-10-26
JP3262806B2 (ja) 2002-03-04
AP9801254A0 (en) 1998-06-30

Similar Documents

Publication Publication Date Title
PA8452001A1 (es) Derivados de macrolidos c-4" sustituidos
PA8452201A1 (es) Derivados de 9-desoxo-9a-aza-9a -homoeritromicina a c-4"sustituidos.
PA8451801A1 (es) Derivados de la 9-oxima eritromicina
CO4930259A1 (es) Derivados 6,6-heterobiciclicos sustituidos y composiciones farmaceuticas que los contienen
PA8442001A1 (es) Derivados de pirimidina biciclica condensada
PA8472301A1 (es) Derivados de isotiazol utiles como agentes anticancerosos
PA8465901A1 (es) Nuevos derivados de la eritromicina
AR019496A1 (es) Azalidas de 13 miembros, composiciones farmaceuticas, uso en la preparacion de medicamentos y preparacion de los mismos
AR029634A1 (es) Compuestos derivados heterociclicos utiles como agentes anticancerosos, composicion farmaceutica y procedimiento de tratamiento
GT199800180A (es) Derivados de la tienopirimidina y de la tienopiridina utiles como agentes anticancerigenos.
AR029175A1 (es) Derivados 2-amino-fenilpurina, un proceso para su preparacion, composicion farmaceutica que los comprende, y el uso de los mismos para la preparacion de un medicamento
ECSP024399A (es) Derivados de benzotiazol
SV1998000029A (es) Compuestos de pirazina ref. pg3186
PA8547701A1 (es) Nucleosidos 4 substituidos.
ES2161290T3 (es) Derivados de quinazolina.
ES2193337T3 (es) Utilizacion de sales de estroncio para el tratamiento de la artrosis.
PA8489501A1 (es) Antibioticos cetolidos
ES2062943B1 (es) Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas.
AR012504A1 (es) Utilizacion de derivados de tetrahidropiridina, para la preparacion de medicamentos para el tratamiento de las enfermedades que provocan unadesmielinizacion.
BR9903737A (pt) Carbamatos em c-11 de macrólidos antibacterianos
MD1560G2 (ro) Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
PA8471801A1 (es) Derivados de higromicina a
ES2122221T3 (es) Compuestos terapeuticos adecuados para el tratamiento de enfermedades conectadas con la deficiencia de glutation, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
SE9103776D0 (sv) New compounds